Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis

Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis

ObjectiveIdiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases with various subtypes, myositis-specific antibodies, and affect multiple systems. The treatment of IIMs remains challenging, especially for refractory myositis. In addition to steroids and traditional...

Full description

Bibliographic Details
Main Authors:	Chao Zhen, Ying Hou, Bing Zhao, Xiaotian Ma, Tingjun Dai, Chuanzhu Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Immunology
Subjects:	rituximab idiopathic inflammatory myopathies meta-analysis efficacy safety
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1051609/full

Similar Items

Development of differential diagnostic models for distinguishing between limb-girdle muscular dystrophy and idiopathic inflammatory myopathy
by: Guangyu Wang, et al.
Published: (2024-12-01)

Biological Therapies in Inflammatory Myopathies
by: Abd El Haleem Natour, et al.
Published: (2023-04-01)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
by: Yunfei Bai, et al.
Published: (2023-03-01)

Idiopathic inflammatory myopathies: Contributions from India
by: Anand Narayan Malaviya
Published: (2020-01-01)

Efficacy of Rituximab in Refractory Inflammatory Myopathy Associated With Coexistence of Behçet's Disease and Antiphospholipid Syndrome
by: Verónica Guiomar, et al.
Published: (2019-11-01)

Experience of polymyositis and antisynthetase syndrome treatment with rituximab
by: S. G. Palshina, et al.
Published: (2015-02-01)

DISABILITY IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
by: Natalia LOGHIN-OPREA, et al.
Published: (2019-03-01)

Juvenile Idiopathic Inflammatory Myopathy at a developing Paediatric Rheumatology Clinic in Trinidad and Tobago: a case series
by: Zafir Latchan, et al.
Published: (2023-05-01)

Successful Corticosteroid-Sparing Effect of Rituximab in the Treatment of Refractory Idiopathic Orbital Inflammatory Disease
by: Emily H. Shao, et al.
Published: (2013-11-01)

The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies
by: Dawn M. Wahezi, et al.
Published: (2023-09-01)

Diagnostic criteria for idiopathic inflammatory myopathies. Problems of their optimization
by: O. A. Antelava, et al.
Published: (2014-09-01)

The Role of Exercise to Improve Physiological, Physical and Psychological Health Outcome in Idiopathic Inflammatory Myopathies (IIM)
by: Lodin K, et al.
Published: (2024-06-01)

Study on advances in the association between autoantibodies and clinical phenotypes in idiopathic inflammatory myopathy
by: ZHANG Hao, CHI Huihui, SU Yutong, YANG Chengde
Published: (2022-06-01)

Idiopathic inflammatory myopathies and hypertension: Possible involvement of hormonal factors
by: Decio Armanini, et al.
Published: (2021-08-01)

Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies
by: Li Qin, et al.
Published: (2021-08-01)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathiesResearch in context
by: Valérie Leclair, et al.
Published: (2023-10-01)

Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospects
by: Ziqi Li, et al.
Published: (2024-11-01)

Evaluation of disease course and major complications in juvenile idiopathic inflammatory myopathy patients
by: Melike Mehveş Kaplan, et al.
Published: (2024-11-01)

Identification of Metabolic Signature Associated with Idiopathic Inflammatory Myopathy Reveals Polyamine Pathway Alteration in Muscle Tissue
by: Jihyun Kang, et al.
Published: (2022-10-01)

Predictive model of diabetes mellitus in patients with idiopathic inflammatory myopathies
by: Qiong Nie, et al.
Published: (2023-04-01)

Underdiagnosis of cardiopulmonary involvement in patients with idiopathic inflammatory myopathies
by: Aleksandra Opinc, et al.
Published: (2021-11-01)

Predictors of cardiac involvement in idiopathic inflammatory myopathies
by: Matilde Bandeira, et al.
Published: (2023-03-01)

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies
by: Joanna E. Parkes, et al.
Published: (2020-06-01)

Electrophysiological, structural, and functional disorders in patients with inflammatory cardiomyopathy secondary to inflammatory myopathy
by: Yingxian Liu, et al.
Published: (2022-07-01)

Idiopathic inflammatory myopathy and non-coding RNA
by: Yang Yang, et al.
Published: (2023-09-01)

Murine models of idiopathic inflammatory myopathy
by: Risa Konishi, et al.
Published: (2023-01-01)

Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population
by: Andrés Hormaza-Jaramillo, et al.
Published: (2022-08-01)

A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies
by: He Chen, et al.
Published: (2020-01-01)

High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
by: Christopher Nelke, et al.
Published: (2022-10-01)

What is new in idiopathic inflammatory myopathies: Mechanisms and therapies
by: Satish V Khadilkar, et al.
Published: (2020-01-01)

Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
by: Juyoung Yoo, et al.
Published: (2021-03-01)

Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes
by: Di Liu, et al.
Published: (2022-10-01)

Cutaneous manifestations in idiopathic inflammatory myopathies
by: Juan Sanz-Correa, et al.
Published: (2022-07-01)

Retinal changes in patients with idiopathic inflammatory myopathies: A case-control study in the MyoCite cohort
by: Rachna Aggarwal, et al.
Published: (2022-11-01)

The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review
by: Julie J. Paik, et al.
Published: (2025-01-01)

Coronary Heart Disease and Cardiovascular Risk Factors in Patients With Idiopathic Inflammatory Myopathies: A Systemic Review and Meta-Analysis
by: Li Qin, et al.
Published: (2022-01-01)

Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases
by: Giulia Morina, et al.
Published: (2025-01-01)

The Expression of Cytokine Profiles and Related Receptors in Idiopathic Inflammatory Myopathies
by: Junyu Zhou, et al.
Published: (2022-04-01)

Morphological differential diagnosis of the main types of inflammatory myopathies
by: S. G. Radenska-Lopovok
Published: (2015-02-01)

Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy
by: Zhao Zhang, et al.
Published: (2023-08-01)